Cost-effective one-hour bacterial identification and antibiotic susceptibility test
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Jerusalem
State: Yerushalayim
Zip:
Country: Israel
BactoByte aims to empower caregivers with one-hour bacterial diagnostics and antibiotic screening capability to improve outcomes, reduce mis-diagnostics, and lower health care costs. Based on a proprietary novel basic method, BactoByte’s assay delivers precise and cost-effective identification and direct antibiotics susceptibility testing with 80-90% improvement of standard turnaround time. Time reduction, sensitivity, and specificity results in decreased mortality rates, fewer hospital days, and avoidance of associated costs of $1K-50K per patient. BactoByte has technology validation and partnerships with leading medical centers.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2019 | Seed Round | 1 | - |
Rationalwave Capital Partners Rationalwave Capital Partners |
7/2019 | Seed Round | 1 | - |
Rationalwave Capital Partners Rationalwave Capital Partners |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|